In 2020, Arena Pharmaceuticals completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Arena Pharmaceuticals has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2020 | 2019 |
|---|---|---|
Total Scope 1 | 53a | 275a |
Total Scope 2 | ||
Unspecified Calculation Method | 160a | 319a |
Total Scope 3 | N/A | N/A |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2020, the total operational greenhouse gas (GHG) emissions of Arena Pharmaceuticals amounted to 213 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2019, the total operational greenhouse gas (GHG) emissions of Arena Pharmaceuticals decreased by 64.14%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a
In 2020, the total Scope 1 emissions of Arena Pharmaceuticals were 53 metric tons of CO₂ equivalent (tCO₂e).a
Compared to the previous year (2019), Arena Pharmaceuticals's Scope 1 emissions decreased by 80.73%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a
In 2020, Arena Pharmaceuticals reported Scope 2 greenhouse gas (GHG) emissions of 160 tCO₂e without specifying the calculation method.a
Compared to the previous year (2019), Arena Pharmaceuticals's Scope 2 emissions (Unspecified Calculation Method) fell by 49.84% in 2020, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption.a
In 2020, Arena Pharmaceuticals reported its Scope 2 emissions using an unspecified methodology.a